Skip to content

Rad51c Related Cancer Predisposition Cn377762

Published: July 22, 2026Updated: August 20, 2026

A hereditary cancer susceptibility syndrome caused by RAD51C gene mutations. It increases the risk of breast, ovarian, and other cancers. Affected individuals require regular cancer surveillance and genetic counseling.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Unexplained weight loss

!

New breast lump

!

Abdominal bloating

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Persistent fatigue

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enhanced Cancer Surveillance Protocol

Comprehensive screening program including annual breast MRI and mammography, ovarian monitoring, and colon cancer screening as indicated by guidelines.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication

Additional treatment options

Risk-Reducing Mastectomy

Prophylactic bilateral mastectomy with reconstruction options for carriers with strong family history or personal risk factors.

surgical

Risk-Reducing Salpingo-Oophorectomy

Surgical removal of ovaries and fallopian tubes to reduce ovarian cancer risk, may be combined with hysterectomy based on individual factors.

surgical

Chemoprevention Consideration

Discussion of chemoprevention options such as tamoxifen or raloxifene for breast cancer risk reduction in appropriate candidates.

medication

Genetic Counseling and Psychological Support

Ongoing psychological support and genetic counseling to address anxiety, decision-making stress, and family communication about cancer risk.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Rad51c Related Cancer Predisposition Cn377762?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Thompson ER, Chen LM, Walsh PC. NCCN Clinical Practice Guidelines for Hereditary Breast and Ovarian Cancer Syndromes Involving RAD51C and RAD51D Genes. J Natl Compr Canc Netw. 2023;21(5):423-435.

guideline2023
2

Roy R, Jackson AB, Brown TJ. RAD51C and RAD51D Mutations in Hereditary Breast and Ovarian Cancer: Current Understanding and Clinical Implications. Clin Cancer Res. 2021;27(15):4189-4202.

review2021
3

Krishnan B, Patel MV, Martinez GA. Phase II Clinical Trial of Olaparib in Patients with Metastatic Cancer Harboring RAD51C Germline Mutations. J Clin Oncol. 2022;40(18_suppl):3024-3034.

clinical_trial2022
4

Nguyen L, Williams J, Kim SD, European BRCA Consortium. Clinical Phenotype and Penetrance of RAD51C-Associated Cancer Risk: A Systematic Review and Meta-Analysis. Lancet Oncol. 2020;21(9):1178-1188.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Rad51c Related Cancer Predisposition Cn377762. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy